Novel Approaches Directed to Prevention and Treatment of Huntington Disease
HAYDEN, Michael R
6 enregistrements totalisant 8,462,692.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $8,462,692 | 6 enregistrements |
Enregistrements
Hayden, Michael R
$3,568,457.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada
HAYDEN, Michael R
$1,679,044.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
Drug Safety and Effectiveness Network (DSEN) Pharmacogenomics of Adverse Events National Team(PREVENT)
HAYDEN, Michael R
$1,400,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2014-2015
Canada
Canada Research Chair Tier 1
HAYDEN, Michael R
$812,719.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
Novel approaches to modulate key targets in the pathogenesis of Huntington Disease
HAYDEN, Michael R
$559,256.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada
microRNA regulation of ABCA1 and its impact on beta cell function
Hayden, Michael R
$443,216.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada
Allele-specific lowering of mutant polyQ proteins as treatment for Huntington disease, spinocerebellar ataxia type 3 and spinocerebellar ataxia type 7